Welch's food processing leftovers entering hydrogen-from-waste cycle

Back in September, a company called NanoLogix announced it had been able to make hydrogen from the waste stream at a Welch Foods juice plant in Pennsylvania. Now, the radio show "The Allegheny Front," an environmental radio program, has taken a closer look at this technology and aired a report last week. You can hear it here (look for "Microbes Turn Waste to Power" and "Welch's Grape Juice Converted into Electricity") or read the transcript of the report here.

The process works like this: during the cleaning process at the plant, a lot of waste water is generated that has a bit of sugar in it. This easy-to-digest liquid is then fed to millions of microorganisms that produce hydrogen. Currently, the NanoLogix tests can get a liter of hydrogen from one gallon of wastewater that contains .3 percent sugar. The goal, though, is to use 16 percent sugar wastewater and get 55 liters of hydrogen from each gallon. Once perfected, the NanoLogix logic goes, this system could be installed at bottlers and beverage makers across the country, and we'll be one step closer to the hydrogen economy.

[Source: NanoLogix, Inc.]

NanoLogix's Hydrogen-From-Waste Technology at Welch's Foods Featured on Environmental Radio Program

HUBBARD, Ohio, Jan. 28 /PRNewswire-FirstCall/ -- NanoLogix, Inc. a nano-biotechnology company is pleased to announce that its hydrogen-from-waste extraction technology currently under development at a Welch's juice plant in Pennsylvania has been the focus of a broadcast article by "The Allegheny Front" - Environmental Radio for Western Pennsylvania". The broadcast was produced by Lisa Ann Pinkerton and aired January 23rd on WYEP- FM, a listener-supported public radio station in Pittsburgh. The archived broadcast can be accessed at: http://alleghenyfront.org/index.html and is titled as both "Microbes Turn Waste to Power" and "Welch's Grape Juice Converted into Electricity".

About NanoLogix, Inc.

NanoLogix is a leading innovator in the research, development, and commercialization of nano-biotechnologies, applications and processes. The Company has 31 granted Patents and 30 Patents Pending for bioreactor-based Hydrogen Production, revolutionary rapid medical testing technologies, potential treatments for sepsis and cancer (via apoptosis), and bioremediation. Information on NanoLogix is available at www.nanologixinc.com.

This press release contains statements, which may constitute "forward- looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Share This Photo X